Skip to content

Bispectral Index Monitoring During Anesthesiologist - Directed Sedation in Scheduled Colonoscopies

Bispectral Index Monitoring During Anesthesiologist - Directed Sedation in Scheduled Colonoscopies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03461029
Enrollment
196
Registered
2018-03-09
Start date
2016-01-30
Completion date
2018-02-20
Last updated
2018-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Keywords

Sedation

Brief summary

The aim of the study is to establish and identify the level of sedation that is performed in the endoscopy rooms of Galdakao Hospital. To do this, the investigators used the BIS monitoring system, which obtains objective values in real time from the anesthesia performed. The monitoring is completed with basic parameters validated by European guidelines (heart rate, blood pressure, oxygen saturation and respiratory rate), capnography and Ramsay sedation scale, widely validated for use outside the operating room. The main work hypothesis was that in at least 10% of the patients BIS values compatible with moderate or deep sedation would be obtained (BIS \<65).

Detailed description

Observational study in patients undergoing scheduled colonoscopy in endoscopy rooms of the Galdakao-Usansolo Hospital. The investigators objectified the level of sedation that was performed in these procedures using Bispectral Index Monitoring, as well as the total dose of medication required and the level of satisfaction obtained after completing the sedation. The incidence of hemodynamic and respiratory complications observed was included, as well as the treatment needed to solve them. A total of 196 patients were needed to obtain statistically significant results. Qualitative variables are expressed in the form of freguencies and percentages and continuous variables in the form of means and stnadard deviations. Comparisions of percentages were made by the Chi square test and the difference of means in the continuous variables by the t test.Stadistical significance will be assumed when p\<0.05. All estadistical analyzes were carried out using SAS V9.4 (SAS Institute, Inc., Carey, NC).

Interventions

The investigators placed on the forehead of all patients the sensor BIS quatroTM, that connects with the monitor, and they registered sedation and recorded the values obtained.

Sponsors

Hospital Galdakao-Usansolo
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Indication of scheduled colonoscopy. * Classification of physical status ASA I, II and III. * Intermitent or persistent mild asthma. * Body Mass Index (BMI) \< 35 kg/m2. * Intact neurological capacity. * Acceptance to participate in the study after signing written informed consent.

Exclusion criteria

* ASA IV. * BMI \> 35 kg/m2. * Allergy to any of the medications using in sedation, or its components. * Known mental or neurological disease. * Chronic Obstructive Pulmonary Disease (COPD) or Obstructive Sleep Apnea. * Chronic opiate users. * Refusal to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Level of sedation1 year.Sedation measured by Bispectral Index Monitoring.

Secondary

MeasureTime frameDescription
Complications related to sedation.1 year.Complications were measured: hypotension, bradicardia, apnea and low oxygen saturation. The medications or maneuvers that were necessary to correct these complications were also evaluated.
Level of satisfaction with the sedation.1 year.The investigators distributed a satisfaction questionnaire to all patients after colonoscopy to find their opinion about the quality of sedation.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026